Real-Time PCR and Digital PCR Market Report: Trends, Forecast and Competitive Analysis to 2030

Real-Time PCR and Digital PCR Trends and Forecast

The future of the global real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets. The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.

A more than 150-page report is developed to help in your business decisions.

Real-Time PCR and Digital PCR by Segment

The study includes a forecast for the global real-time PCR and digital PCR by product type, technology, application, end use, and region.

Real-Time PCR and Digital PCR Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Reagents and Consumables
• Instruments
• Software

Real-Time PCR and Digital PCR Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Quantitative PCR
• Digital PCR

Real-Time PCR and Digital PCR Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Clinical
• Research
• Forensic
• Others

Real-Time PCR and Digital PCR Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals and Diagnostic Centers
• Research Laboratories and Academic Institutes
• Pharmaceutical and Biotechnology
• Clinical Research Organizations
• Forensic Laboratories
• Others

Real-Time PCR and Digital PCR Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Real-Time PCR and Digital PCR Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies real-time PCR and digital PCR companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the real-time PCR and digital PCR companies profiled in this report include-

• F. Hoffmann La Roche
• Takara Bio
• Becton and Dickinson
• Agilent Technologies
• Merck KGaA
• Qiagen
• Abbott Laboratories
• Thermo Fisher Scientific
• Danaher
• Bio Rad Laboratories

Real-Time PCR and Digital PCR Market Insights

Lucintel forecasts that clinical is expected to witness highest growth over the forecast period.

North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region.

Features of the Global Real-Time PCR and Digital PCR Market

Market Size Estimates: Real-time PCR and digital PCR market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Real-time PCR and digital PCR market size by various segments, such as by product type, technology, application, end use, and region in terms of ($B).

Regional Analysis: Real-time PCR and digital PCR market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the real-time PCR and digital PCR market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the real-time PCR and digital PCR market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the real-time PCR and digital PCR market size?

Answer: The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030.

Q.2 What is the growth forecast for real-time PCR and digital PCR market?

Answer: The global real-time PCR and digital PCR market is expected to grow with a CAGR of 7.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the real-time PCR and digital PCR market?

Answer: The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.

Q4. What are the major segments for real-time PCR and digital PCR market?

Answer: The future of the real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets.

Q5. Who are the key real-time PCR and digital PCR market companies?

Answer: Some of the key real-time PCR and digital PCR companies are as follows:

• F. Hoffmann La Roche
• Takara Bio
• Becton and Dickinson
• Agilent Technologies
• Merck KGaA
• Qiagen
• Abbott Laboratories
• Thermo Fisher Scientific
• Danaher
• Bio Rad Laboratories

Q6. Which real-time PCR and digital PCR market segment will be the largest in future?

Answer: Lucintel forecasts that clinical is expected to witness highest growth over the forecast period.

Q7. In real-time PCR and digital PCR market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the real-time PCR and digital PCR market by product type (reagents and consumables, instruments, and software), technology (quantitative PCR and digital PCR), application (clinical, research, forensic, and others), end use (hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology, clinical research organizations, forensic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?